|
Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks Yahoo FinanceEli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand CNBCEli Lilly forecasts weaker Q4 sales of weight-loss drug, Mounjaro than expected Yahoo FinanceEli Lilly's stock falls
|
|
Moderna now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, most of which will come in the second half of the year.
|
|
